Abstract: A system and a method to treat lice and nits on a head of a patient. The system includes a cap for defining an airtight space around the head and a container for storing a mixture of gases for treating lice, a gas release mechanism for delivering the mixture of gases into the airtight space as an aerosol, and a gas distribution device having plurality of gas delivery pins. The mixture of gases causes irreversible damage to essential mechanisms of the lice. According to another embodiment of the present invention the system includes a cap for defining an airtight space around the head and an active agent container. The active agent of the type of acetic acid, stored in a liquid state, and vaporized during use, then circulated toward the cap.

Abstract: A system and a method to treat lice and nits on a head of a patient. The system includes a cap for defining an airtight space around the head and a container for storing a mixture of gases for treating lice, a gas release mechanism for delivering the mixture of gases into the airtight space as an aerosol, and a gas distribution device having plurality of gas delivery pins. The mixture of gases causes irreversible damage to essential mechanisms of the lice. According to another embodiment of the present invention the system includes a cap for defining an airtight space around the head and an active agent container. The active agent of the type of acetic acid, stored in a liquid state, and vaporized during use, then circulated toward the cap.

Abstract: A system and a method treat lice and nits on a head of a patient. The system includes a cap for defining an airtight space around the head and a container for storing a mixture of gases for treating lice, a gas release mechanism for delivering the mixture of gases into the airtight space as an aerosol, and a gas distribution device having plurality of gas delivery pins. The mixture of gases causes irreversible damage to essential mechanisms of the lice. According to another embodiment of the present invention the system includes a cap for defining an airtight space around the head and an active agent container. The active agent of the type of acetic acid, stored in a liquid state, and vaporized during use, then circulated toward the cap.

Abstract: A system and a method for treating lice and nits on a head of a patient. The system includes a cap for defining an airtight space around the head and a container for storing a mixture of gases for treating lice, a gas release mechanism for delivering the mixture of gases into the airtight space as an aerosol, and a gas distribution device having plurality of gas delivery pins. The mixture of gases causes irreversible damage to essential mechanisms of the lice. According to another embodiment of the present invention the system includes a cap for defining an airtight space around the head and an active agent container. The active agent of the type of acetic acid, stored in a liquid state, and vaporized during use, then circulated toward the cap.

Abstract: A system and a method for treating lice and nits on a head of a patient. The system includes a cap for defining an airtight space around the head and a container for storing a mixture of gases for treating lice, a gas release mechanism for delivering the mixture of gases into the airtight space as an aerosol, and a gas distribution device having plurality of gas delivery pins. The mixture of gases causes irreversible damage to essential mechanisms of the lice.

Abstract: Specific anti-heparanase antibodies which bind specifically to heparanase having sequence homology to human heparanase, which can be used to treat and diagnose conditions associated with heparanase catalytic activity, for purification of heparanase, and for drug development in heparanase associated conditions are disclosed.

Abstract: A method of treating a condition associated with heparanase expression by administering a heparanase activity neutralizing monoclonal anti-heparanase antibody, the monoclonal anti-heparanase antibody being for neutralizing heparanase catalytic activity.

Abstract: Specific anti-heparanase antibodies which bind specifically to heparanase having sequence homology to human heparanase, which can be used to treat and diagnose conditions associated with heparanase catalytic activity, for purification of heparanase, and for drug development in heparanase associated conditions are disclosed.

Abstract: Specific anti-heparanase antibodies which bind specifically to heparanase having sequence homology to human heparanase, which can be used to treat and diagnose conditions associated with heparanase catalytic activity, for purification of heparanase, and for drug development in heparanase associated conditions are disclosed.

Abstract: A method of treating a condition associated with heparanase expression by administering a heparanase activity neutralizing monoclonal anti-heparanase antibody, the monoclonal anti-heparanase antibody being for neutralizing heparanase catalytic activity.

Abstract: A monoclonal antibody elicited by a heparanase protein or an immunogenical portion thereof, the monoclonal antibody specifically inhibits heparanase activity.

Abstract: Bacterial, yeast and animal cells and methods for overexpressing recombinant heparanase in cellular systems, methods of purifying recombinant heparanase therefrom and modified heparanase species which serve as precursors for generating highly active heparanase by proteolysis.

Abstract: A monoclonal antibody elicited by a heparanase protein or an immunogenical portion thereof, the monoclonal antibody specifically inhibits heparanase activity.